Navigation Links
AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
Date:12/7/2009

Evaluable 6.4 months 25 months Patients 95% CI (5.3, 7.1) 95% CI (15.5, NR) (n=73) ------------------------------------------------------------------------- NR = Not Reached * Median PFS and median TTP were identical, as no patient deaths occurred prior to progression. ** Kaplan Meier methodology was used to determine overall survival figures.

Of particular interest was the comparison of evaluable patients who were previously refractory and the patients who were relapsed to a bortezomib-based regimen.

    Median PFS and OS for bortezomib relapsed vs. refractory were as follows:

    -------------------------------------------------------------------------
    Bortezomib Relapsed
    vs. Refractory              Median PFS*         Median OS**
    -------------------------------------------------------------------------
    Bortezomib Relapsed         8.8 months            Not Reached at
    (n=20)           95% CI (6.3, 11.2)    38+ months  95% CI
                                                      (25, NR)
    -------------------------------------------------------------------------
    Bortezomib Refractory       5.7 months            22.5 months
    (n=53)           95% CI (4.3, 6.4)     95% CI (12.3, NR)
    -------------------------------------------------------------------------

    * Median PFS and median TTP were identical, as no patient deaths
    occurred prior to progression.
    ** Kaplan Meier methodology was used to determine overall survival
    figures.

No unexpected adverse events have been observed. Toxicities were manageable with supportive care.

"We congratulate our partner Keryx and their principle investigators Dr. Richardson and Dr. Anderson for the encouraging results for perifosine in multiple myeloma which further demonstrate perifosine's potential as a novel treatment for this indication. We now look for
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 CIRTEC Medical Systems ... services for complex Class III implantable devices and minimally ... UT Dallas-led initiative aimed at identifying potentially marketable biomedical ... institutions and moving them more efficiently from the laboratory ... history of working with the world's largest OEMs and ...
(Date:6/3/2015)... June 03, 2015 Innovative biomass supply ... announced its platinum sponsorship of the first annual ... the Royal Sonesta Hotel in New Orleans, June 9-10, ... in an effort to further the advancements of feedstock ... and policies, overall logistics, yield improvement and more. ...
(Date:6/3/2015)... MIAMI (PRWEB) June 03, 2015 ... Cell Training, Inc. have announced plans to conduct Romania’s ... 27-28, 2015. Through an alliance with Miami-based Stem Cell ... will conduct the Adipose and Bone Marrow Stem Cell ... is a reconstructive plastic surgery specialist practicing in Bucharest ...
(Date:6/2/2015)... CALGARY , June 2, 2015 /CNW/ - Shell today ... fuel in the premium category with an exhibit the ... Square, that included interactive demonstrations for media and the ... New Shell V-Power NiTRO+ Premium Gasoline provides the best ... diminished engine performance: engine wear, gunk and corrosion. ...
Breaking Biology Technology:CIRTEC Medical Systems to support new UT Dallas-led Initiative to deliver biomedical technologies from laboratory bench to bedside more efficiently 2Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 2Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 3Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 2Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 4
... The Milwaukee Brewers will soon have their ... at Miller Park, officials announced Thursday. , ,Eastman Kodak ... provide a Directview CR 850 computer-operated radiography ... be used to generate high-resolution digital X-rays of injured ...
... If you had blinked, you would have missed two security ... Web server last Wednesday. , ,Dane Deutsch and Pete Adams, ... used a simple tool to gain complete control of a ... E-Business Institutes conference at the Monona Terrace, without leaving a ...
... Ralph Kauten. Source: Teresa Esser. Ralph is one of ... of bioscience, said Frank Langley, president and CEO of Point ... Kauten to admit that his success in high-tech entrepreneurship is ... Kauten said in an interview. Ive been a lucky guy. ...
Cached Biology Technology:Hacking tools are simple and widely available, security experts say 2Ralph Kauten on how to raise angel financing 2Ralph Kauten on how to raise angel financing 3Ralph Kauten on how to raise angel financing 4
(Date:5/28/2015)... ALLEN, Va. , May 28, 2015 /PRNewswire/ ... the release of a new report titled "Markets ... materials (reversible polymers, inorganic capsule and vascular systems, ... coatings) will grow to around $2.7 billion by ... deliverable from n-tech,s extensive coverage of smart materials. Other ...
(Date:5/25/2015)... , May 25, 2015  Australia,s market for wearable ... although 2014 saw the advent of several trials and ... April 2015 is expected to ignite interest in wearables ... Australia . This in turn will ... and drive new partnerships amongst vendors and distributors. ...
(Date:5/21/2015)... May 21, 2015 According ... Market by Solutions (Hardware, Software, Services), by Applications (Surveillance ... others), by End-Users (Military & Defense & Commercial) ... Thermal Imaging Market is expected to grow from ... 2020, at a Compound Annual Growth Rate (CAGR) ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4
... many benefits for adults, teens, and youngsters. It is ... during fetal growth during gestation. Now that scientists have ... risk to a fetus, studies are underway to examine ... now complete. Entitled The Effects of Maternal Exercise on ...
... a little genetics in high school has heard of adenine, ... make up the DNA code. But those are not the ... has drawn attention to a fifth nucleotide, 5-methylcytosine (5-mC), that ... regulate which genes are expressed. And now there,s a sixth. ...
... single crafty protein allows the deadly bacterium Salmonella enterica ... cellular functions to avoid destruction, Yale researchers report in the ... This evolutionary slight-of-hand sheds new insights into the lethal tricks ... people a year. "In evolutionary terms, this hijacking of ...
Cached Biology News:Effects of maternal exercise on fetal breathing movements 2New nucleotide could revolutionize epigenetics 2New nucleotide could revolutionize epigenetics 3New nucleotide could revolutionize epigenetics 4Yale researchers uncover secrets of salmonella's stealth attack 2
... is an advanced RACE (rapid amplification of ... of amplifying full-length 5' and 3' cDNA ... SuperScript II Reverse Transcriptase (RT) for improved ... long and complex mRNA. The RNase H ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
2ndGen Predilute antibody for staining tissue sections. Optimized for use with Zymeds Histostain-PLUS, NBA, HistoST5050, and Cap-Plus IHC Kits.Labeling: ASR...
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
Biology Products: